1 Medical Affairs, Bausch + Lomb, Rochester, New York.
2 Nonclinical Safety, R&D, Bausch + Lomb, Rochester, New York.
J Ocul Pharmacol Ther. 2019 Jun;35(5):291-300. doi: 10.1089/jop.2018.0136. Epub 2019 Mar 23.
To evaluate rheological properties, dissolution, and ocular pharmacokinetics of loteprednol etabonate (LE) (submicron) ophthalmic gel 0.38%. The viscosity of the LE gel 0.38% formulation was measured with a controlled stress rheometer. Dissolution kinetics were evaluated in a fixed-volume and flow-through assay. Rabbits received a single instillation of LE (submicron) gel 0.38% (both eyes), and concentrations of LE in ocular tissues were determined through 24 h by liquid chromatography with tandem mass spectrometry. Where indicated, comparators included micronized LE gel 0.38%, 0.5% (Lotemax gel), and 0.75%. LE (submicron) gel 0.38% exhibited shear-thinning characteristics similar to LE gel 0.5% with nearly identical yield stress. LE (submicron) gel 0.38% released 2.6-fold more LE into the dissolution medium than micronized LE gel 0.5% over 30 s in the fixed-volume dissolution assay, and submicron LE attained higher concentrations of dissolved LE than micronized LE gel 0.38% in the flow-through dissolution assay. In rabbits, the maximal concentration and area-under-the-curve over 24 h for LE in aqueous humor were 2.5- and 1.8-fold higher, respectively, for LE (submicron) gel 0.38% versus micronized LE gel 0.5% (both < 0.001). Pharmacokinetic parameters were similar for most other tissues. LE (submicron) gel 0.38% demonstrated similar rheological properties to micronized LE gel 0.5% but faster dissolution, thus providing similar or higher LE concentrations in the aqueous humor, cornea, and iris-ciliary body after ocular dosing in rabbits despite a lowered concentration of drug in the formulation.
为了评估 loteprednol etabonate(LE)(亚微米)眼用凝胶 0.38%的流变特性、溶解和眼部药代动力学。使用控制应变速率流变仪测量 LE 凝胶 0.38%制剂的粘度。在固定体积和流动通过测定法中评估溶解动力学。兔子接受单次 LE(亚微米)凝胶 0.38%(双眼)滴眼,通过液质联用色谱法在 24 小时内定量眼部组织中的 LE 浓度。在有指示的情况下,比较剂包括微粉化 LE 凝胶 0.38%、0.5%(Lotemax 凝胶)和 0.75%。LE(亚微米)凝胶 0.38%表现出类似于 0.5%LE 凝胶的剪切稀化特性,几乎具有相同的屈服应力。在固定体积溶解测定中,在 30 秒内,LE(亚微米)凝胶 0.38%释放到溶解介质中的 LE 比微粉化 LE 凝胶 0.5%多 2.6 倍,而亚微米 LE 在流动通过溶解测定中达到比微粉化 LE 凝胶 0.38%更高的溶解 LE 浓度。在兔子中,房水中 LE 的最大浓度和 24 小时 AUC 分别为 LE(亚微米)凝胶 0.38%与微粉化 LE 凝胶 0.5%相比,分别高 2.5 倍和 1.8 倍(均 <0.001)。大多数其他组织的药代动力学参数相似。LE(亚微米)凝胶 0.38%表现出与微粉化 LE 凝胶 0.5%相似的流变特性,但溶解更快,因此尽管制剂中的药物浓度较低,但在兔子眼部给药后,房水、角膜和虹膜睫状体中的 LE 浓度相似或更高。